SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-150900
Filing Date
2014-04-21
Accepted
2014-04-21 16:53:10
Documents
2
Period of Report
2014-06-03
Effectiveness Date
2014-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY MATERIALS d711891ddef14a.htm DEF 14A 494899
2 GRAPHIC g711891pc_pg002.jpg GRAPHIC 4122
  Complete submission text file 0001193125-14-150900.txt   501961
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-55021 | Film No.: 14774249
SIC: 2834 Pharmaceutical Preparations